ScandiDos launches Delta4 Insight which is immediately available to sell to customers in Europe and parts of Asia.
Delta4 Insight provides radiotherapy clinics with an independent QA solution that verifies the accuracy and quality of their treatment plans. Featuring a state-of -the-art Monte Carlo dose engine, enabling exceptional calculation accuracy, giving the clinic full confidence that the planned treatments fulfill the prescription for each specific patient. Delta4 Insight extends the Delta4 family of products into a full end-to-end verification solution.
Delta4 Insight – Golden standard secondary dose calculation
Delta4 Insight is an independent secondary 3D dose calculation software that utilizes a Monte Carlo engine to verify the calculations of a clinic’s Treatment Planning System (TPS). It provides the user with independent verification of the dose calculation algorithm and verifies that the calculations the TPS makes are accurate.
Delta4 Insight completes the ScandiDos patient QA product portfolio which now covers patient QA from prescription to final fraction. Not only can Delta4 users expect to increase the workflow efficiency but, most importantly, they can also carry out their work with full confidence that throughout the whole treatment process the dose delivered to patients is safe.
”Our ambition when developing Delta4 Insight was to extend our Delta4 family of products into a full end-to-end verification solution where the customer can be confident that Delta4 provides the true values and not just the deviations”, says Görgen Nilsson, CTO, and founder.
Delta4 Insight will initially be available in most of Europe and key markets in Asia, but further markets will be addressed based on regulatory approvals. Primary target groups are current Delta4 Phantom+ customers, today over 800 clinics, and radiotherapy clinics buying the Delta4 Phantom+.
” I am very pleased that we are now bringing Delta4 Insight to market. Together with ScandiDos’ existing products Delta4 Phantom+ and Delta4 Discover, Delta4 Insight will offer independent and complete verifications of all treatment steps from prescription to final treatment fraction”, says Gustaf Piehl, President & CEO.
Gustaf Piehl, CEO, ScandiDos: firstname.lastname@example.org, +46 18-472 30 20
ScandiDos AB (publ), 556613-0927
Uppsala Science Park, 751 83 Uppsala
ScandiDos is an innovative forward-thinking company with groundbreaking software and hardware solutions for patient quality assurance in modern radiation therapy. Our Delta4 Family of products delivers a comprehensive QA solution, making the treatment process safe and efficient. We reinforce the confidence in radiotherapy clinics by providing professionals at the clinics with power and performance through independent QA.
The head office is in Uppsala Science Park, where product development is carried out. Sales are carried out by sales offices in the USA, Malaysia, and France, directly in the Nordic countries, and through distributors in over 50 countries.
ScandiDos is listed on NASDAQ First North Stockholm with the ticker code SDOS. Certified adviser is Erik Penser Bank (08-463 83 00, email@example.com). Additional investor information can be found at Scandidos.com. Product information can be found on Delta4family.com
This information is information that ScandiDos is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-02-25 08:50 CET.
WANT TO LEARN MORE ABOUT FAST AND INDEPENDENT QA?
Book a demo
Get the answers you need, connect with a Delta4 expert!